Eye - Figures and tables for article: Alphagan allergy may increase the propensity for multiple eye-drop allergy

Eye

FROM:

Alphagan allergy may increase the propensity for multiple eye-drop allergy

S A Osborne, D M I Montgomery, D Morris and I C McKay

BACK TO ARTICLE

Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Figure 1.

The curves showing the kinetics of development of allergy for ten different drugs

Full figure and legend (103K)

Table 1 - Drug codes and preservatives contained in each preparation - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 1 - Drug codes and preservatives contained in each preparation.

Table 2 - Number of times treatment stopped and reasons for stopping - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 2 - Number of times treatment stopped and reasons for stopping.

Table 3 - Number of times treatment stopped per 100,000 patient treatment days and reasons for stopping - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 3 - Number of times treatment stopped per 100,000 patient treatment days and reasons for stopping.

Table 4 - Estimates of mean time to develop allergy - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 4 - Estimates of mean time to develop allergy.

Table 5 - Table formulated to assess drug cross-reactivity - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 5 - Table formulated to assess drug cross-reactivity.

Table 6 - Associations between allergies to two drugs - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 6 - Associations between allergies to two drugs.

Table 7 - Measurement of association of allergies to two drugs - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 7 - Measurement of association of allergies to two drugs.

Table 8 - Statistical significance of cross-reactivity - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 8 - Statistical significance of cross-reactivity.

Table 9 - Measurement of association of allergies to two drugs, separating Timoptol from Timoptol LA - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 9 - Measurement of association of allergies to two drugs, separating Timoptol from Timoptol LA.

Table 10 - Patients who developed allergy to both Alphagan and Timoptol, classified according to which drug was used first([ast]) - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 10 - Patients who developed allergy to both Alphagan and Timoptol, classified according to which drug was used first(^*).

Table 11 - Patients who developed allergy to both Alphagan and Trusopt, classified according to which drug was used first([ast]) - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 11 - Patients who developed allergy to both Alphagan and Trusopt, classified according to which drug was used first(^*).

Table 12 - Patients categorised according to whether they did or did not receive filtration surgery before or at the time of starting therapy with a given drug for the first time, and according to whether that drug treatment was stopped because of allergy - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 12 - Patients categorised according to whether they did or did not receive filtration surgery before or at the time of starting therapy with a given drug for the first time, and according to whether that drug treatment was stopped because of allergy.

BACK TO ARTICLE